Tony Gershlick

392 posts

Tony Gershlick banner
Tony Gershlick

Tony Gershlick

@agershlick

Jazz interventionalist specialising in coronary reconstruction

Leicester, England เข้าร่วม Eylül 2019
37 กำลังติดตาม708 ผู้ติดตาม
Tony Gershlick
Tony Gershlick@agershlick·
It can only be hypothysis generating Dont over rinterpret
Nicholas Mills@HighSTEACS

#RAPIDCTCA #AHA2020 Significant reduction in invasive coronary angiography with no evidence of harm in acute coronary syndrome. Need to look at cost effectiveness and learn from this trial and others how to select patients for #CTCA

English
1
0
11
0
Aaysha Cader
Aaysha Cader@aayshacader·
#AHA20 @AHAMeetings RAPID-CTCA: Early CTCA in intermediate/high-risk pts with suspected ACS at ED -No difference in all-cause death/subsequent MI -No effect on the overall Rx & prevention of ACS or one-year outcomes ~50% non-obstructive CAD @mirvatalasnag @andrew_ludman
Aaysha Cader tweet mediaAaysha Cader tweet mediaAaysha Cader tweet mediaAaysha Cader tweet media
English
4
25
47
0
Tony Gershlick
Tony Gershlick@agershlick·
These are relevant issues to us as cardiologists working in a world where all sorts of factors (systemic&local) other than than the obvious ones impact on outcomes in ACS patients. We have a stellar cast to discuss the impact of systemic inflammatory condition on ACS. Join us !!
Millbrook Medical Conferences@MillbrookMed

The Impact of Covid-19 Pandemic on Acute Coronary Syndromes e-conference goes live in less than 2 weeks Wednesday 25 November 10:00 -17:00 GMT FREE registration: bit.ly/ACSRegistry Speakers include @mmamas1973 @SukhNijjer Valentin Fuster, Bernard Gersh & more Programme👇

English
0
4
15
0
Tony Gershlick
Tony Gershlick@agershlick·
These posts have been hugely successful over the years The perfect blend of exposure to & involvement in high level CHIP PCI &TAVI with the underlying theme of evidence-based practice in a Unit that has for many years been at the cutting edge of clinical research trials. Join us
Andrew Ladwiniec@ALadwiniec

We have an interventional fellow post out at Glenfield Hospital, Leicester. @leic_hospital. An opportunity to train in complex PCI or structural intervention depending on interest and experience. @agershlick @ShaziaTHussain1 @Leic_hospital @BCIS_uk jobs.nhs.uk/xi/vacancy/916…

English
0
5
22
0
Tony Gershlick
Tony Gershlick@agershlick·
We agree then No targets unless scientifically targeted but this is a priority aim
jcspratt@jcspratt

@agershlick Yes agree that targets need to have some validity, but absence of validated targets is responsible for the variability of care currently damaging the field.

English
0
0
1
0
Tony Gershlick
Tony Gershlick@agershlick·
Agree of course and not advocating qualitative assessment when there is uncertainty. However your proposed "objective targets" need to be proven to be more than a randomly plucked number and should have impact ..POEM..patient oriented hard outcomes I am sure you agree
jcspratt@jcspratt

@agershlick Flip side of that is that without clear, objective targets (MSA / iFR) a successful Intervention is defined in binary terms as stent implantation or visual estimation of flow.

English
1
1
2
0
Tony Gershlick
Tony Gershlick@agershlick·
Real danger is the chasing of a number (>0.95)that needs to be proven to be beneficial w/out leading to the obvious risk of complications including edge tears and sent disruption, not to mention cost. Too early to promote a number. eg ill be interest. to see if focal 0.9=hard EP
Gregg W. Stone MD@GreggWStone

@ajaykirtane @MitulKanzariaMD @DrAllenJ @manesh_patelMD Regarding increased stent usage, it will depend on the cause of the residual gradient. It may only require a larger or higher pressure balloon inflation. If focal, e.g. an unrealized edge dissection or unseen focal stenosis it might require a new stent - but that's a good thing.

English
1
0
4
0
Tony Gershlick
Tony Gershlick@agershlick·
Thanks for this comment-the trial is testing 1 strategy but at different times therefore IF the results are +ve for v early then that will be generalizable if PCI for N-STEMI is available in that country. Also our patient population are very heterogenous within the incl criteria
Dr Sana Sheikh@sana_epienthu

@RapidNSTEMI @LeedsHospitals @LeedsPci @agershlick @drtomkite @RapidNSTEMI the trial is investigating an important clinical management which may result in change in guidelines. Will the investigators consider expanding it later to LMICs to make it more generalizable?

English
0
0
1
0
Tony Gershlick รีทวีตแล้ว
EUROSHOCK
EUROSHOCK@EUROSHOCKstudy·
Later today, Manel Sabate @idibaps will present our #H2020 EURO SHOCK study at #ECMOBARNA2020 Many thanks to @ECMOHUVH for giving us the platform to spread the word about this very important project!
ECMO Barcelona@ECMOHUVH

Tercer día del #ECMOBARNA2020 Tres ponencias de expertos en #ECMO VA #ECPR @EUROSHOCKstudy Y después casos clínicos interactivos! A preparar el Kahoot! @GetKahoot. El ganador recibirá una camiseta ECMOBARNA y un libro @ELSOOrg @EuroELSO @FOAMecmo @jrdelbrio @EduardArgudo

English
0
5
6
0